AMR locations nationwide are currently enrolling in investigational Adult RSV vaccine clinical research studies. Respiratory Syncytial Virus – or RSV – is most commonly discussed in children ages newborn to four. However, RSV, much like the flu or coronavirus, can cause long-term damage to the lungs. It can be life-threatening for adults 60 years and older and for those with compromised health conditions.

According to the CDC, it is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the United States due to RSV infections per year. In 2018, more elder Americans died from RSV infection than the common flu.

To learn more, call our enrollment line: 1-888-259-1231

AMR locations nationwide are currently conducting several COVID-19 investigational clinical research studies. As with all studies, some exclusions will apply. However, we will have multiple studies needing participants from all walks of life. Compensation will be available for time and travel.

COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Treatment Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine (ages 18+ and 5-17) (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

AMR locations nationwide are participating in ORCA-2, a multicenter, double-blinded, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of cytisinicline in adult smokers.  In this study, the sponsor, Achieve Life Sciences, wants to find out if utilizing cytisinicline can increase cigarette smoking abstinence.  To qualify, participants must be male or female, ages 18+ who are currently daily smokers (averaging at least 10 cigarettes per day upon completing a 7-day screening smoking diary) and who intend to quit smoking.  Other study requirements apply.

AMR has multiple Healthy Volunteer Clinical Research Studies enrolling throughout the continental United States.  A “healthy volunteer” is someone with no known significant health problems who participates in a clinical research study to test a new drug, an investigational vaccination, a medical device or a medical intervention.    No insurance is required and qualified volunteers may receive compensation for their time and travel.  Listed below are our current and upcoming Healthy Volunteer clinical research studies listed by indication.

RSV Vaccine Clinical Research Study (healthy volunteers ages 60+)

This is an Investigational RSV Vaccine Clinical Research Study for healthy volunteers 60+ years of age.  Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract.  In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold.

El Dorado:  316-600-5127
[email protected]
Kansas City:  816-943-0770
[email protected]
Miami:  305-445-5637
[email protected]

Chikungunya Vaccine Clinical Research Study (healthy volunteers ages 18+)

Chikungunya virus (CHIKV) is spread by the bite of an infected mosquito. Outbreaks have occurred in Africa, Asia, Europe and the Indian and Pacific Oceans. This Investigational Chikungunya Vaccine Clinical Research Study is an important part of preventing future global pandemics.

El Dorado: 316-600-5127
[email protected]
Kansas City: 816-943-0770
[email protected]
Knoxville: 865-305-3784
[email protected]
Las Vegas: 702-545-6840
[email protected]
Lexington: 859-264-8999
[email protected]
Mobile: 251-414-1984
[email protected]
New Orleans: 504-821-2273
[email protected]
Newton: 316-283-0828
[email protected]
Norfolk: 757-627-7446
[email protected]
Tempe: 602-759-7559
[email protected]
Wichita-East: 316-689-6652
[email protected]

Flu Vaccine Clinical Research Study (healthy volunteers 50+)

This Investigational Flu Vaccine Clinical Research Study is for healthy volunteers 50 years of age and older.

Kansas City: 816-943-0770
[email protected]
Lexington: 859-264-8999
[email protected]
Mobile: 251-414-1984
[email protected]
Newton: 316-283-0828
[email protected]
Tempe: 602-759-7559
[email protected]
Wichita-East: 316-689-6652
[email protected]